Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | PDE9A | O76083 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.35 |
| ▸ | GRM5 | P41594 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.35 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.35 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23427322 | 0.89 | ADORA2A (0.46) | ADORA2AALDH1A1ALOX15HSD17B10PDE9A | |
| SCHEMBL23426514 | 0.89 | ADORA2A (0.46) | ADORA2AALDH1A1ALOX15HSD17B10PDE9A | |
| SCHEMBL23426866 | 0.88 | ADORA2A (0.41) | ADORA2AALDH1A1ALOX15HSD17B10PDE9A | |
| SCHEMBL23427731 | 0.88 | ADORA2A (0.39) | ADORA2AALDH1A1ALOX15HSD17B10PDE9A | |
| SCHEMBL23427301 | 0.88 | ADORA2A (0.39) | ADORA2AALDH1A1ALOX15HSD17B10PDE9A | |
| SCHEMBL25575882 | 0.87 | CA1 (0.42) | ALDH1A1ALOX15HSD17B10KDM4EHPGD | |
| SCHEMBL23427741 | 0.87 | ADORA2A (0.38) | ADORA2AALDH1A1ALOX15HSD17B10PDE9A | |
| SCHEMBL20109957 | 0.84 | CA1 (0.40) | ALDH1A1HSD17B10KDM4EHPGDCA1 | |
| SCHEMBL23427490 | 0.83 | TNKS (0.36) | ADORA2AALDH1A1KDM4EHPGDCYP1A2 | |
| SCHEMBL23427224 | 0.83 | TNKS (0.34) | ADORA2AALDH1A1PDE9AKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11991927-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-05-21 | — | — | US | disclosed |
| US-20230301179-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230174560-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-08 | — | — | US | disclosed |
| US-20230165130-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-25 | — | — | US | disclosed |
| US-20210249610-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-08-12 | — | — | US | disclosed |
| EP-3859812-A1 | ORGANIC LIGHT-EMITTING DEVICE | Samsung Electronics Co., Ltd. (KR) | 2021-08-04 | — | — | EP | disclosed |
| US-20210167299-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210167299-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CYP1A1, AOX1, OXER1 | ADORA2A 1421/4885ALDH1A1 76/4885ALOX15 516/4885 |
| US-20230165130-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, CYP2E1, AOX1 | ADORA2A 3764/4885ALDH1A1 43/4885ALOX15 362/4885 |
| US-20230174560-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CRY1, AOX1, CYP1A1 | ADORA2A 3495/4885ALDH1A1 11/4885ALOX15 308/4885 |
| US-20230301179-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | CRY1, AOX1, CYP1A1 | ADORA2A 3726/4885ALDH1A1 11/4885ALOX15 283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.